Protalix BioTherapeutics to Announce Third Quarter 2026 Financial Results and Business Update on November 10, 2026
<p>Company to host conference call and webcast at 8:00 a.m. ET CARMIEL, Israel, Nov. 3, 2026 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production, and commercialization of innovative therapeutics...</p>
Read original article ↗
Related Articles
Celerant and Worldpay Expand Partnership to Simplify Retailer Cash Flow
ISELIN, N.J., Nov. 3, 2026 /PRNewswire/ -- Celerant Technology, an industry leader in retail software, eCommerce, and di
Wi-Fi, Bluetooth LE, Thread, and on-device AI on a single chip, with existing software and tools, built for billions of
New START site at the IRCCS Istituto Nazionale Tumori Regina Elena will expand access to cancer clinical trials for pati
edgeAI Selects Efficient Computer's Electron E1 for Next-Generation Physical AI Products
The Electron E1 enables edgeAI to significantly reduce energy consumption and BOM costs, while running complex AI models